Regulatory professionals, device engineers and digital health experts gathered last month in Annapolis, Maryland, for the spring meeting of the Orthopaedic Surgical Manufacturers Association (OSMA). During a series of insightful and informative panel discussions, the industry reps weighed in on the digitalization of healthcare and what it will take to capitalize on AI-powered innovation in the orthopedic space. AI is rapidly transforming the orthopedic device industry in the ways new technologies are developed, regulated and adopted.
“The OSMA Spring Meeting underscored a pivotal moment for digital health and the orthopedic industry,” said Suchi Basu, Ph.D., RAC, Director of Regulatory Affairs for Digital Surgery, Power Tools and Arthroscopic Equipment Solutions at Johnson and Johnson MedTech. “The medical device industry is evolving at an unprecedented pace with advancements in AI, wearables, digital diagnostics, connected health platforms, 3D printing, digital twins and robotics. These innovations are creating devices that are smarter, more precise and seamlessly integrated into patient care.”
Dr. Basu said the insights shared at the OSMA meeting emphasized the importance for collaboration among all stakeholders —manufacturers, regulators, trade associations and healthcare providers — to effectively navigate the complexities of this changing landscape.
“Striking a balance between fostering innovation and ensuring patient safety and access will be vital challenges as we move forward,” she said. “As we embrace this digitally-driven era, the integration of advanced technologies like AI and machine learning into healthcare practices, particularly in orthopedics, must be underpinned by a proactive and supportive regulatory framework.
“It is through these collaborations and adaptations that the healthcare industry can unlock its full potential for transformative change.”
Image Credit: Dan Cook / BONEZONE